PERSPECTA

News from every angle

← Back to headlines

Several Companies Reaffirm 2026 Revenue Guidance

Jazz Pharmaceuticals, AtriCure, and HealthStream have each reaffirmed their respective revenue guidance for 2026. These companies also provided updates on specific product developments and investment strategies.

6 May, 06:52 — 6 May, 06:52
PostShare

Sources

Showing 1 of 1 sources
seeking-alphaMixed45m ago

Jazz reaffirms $4.25B-$4.5B 2026 revenue guidance while targeting an Aug. 25, 2026 PDUFA for Ziihera in GEA

Read full article →

Related Stories

Amazon's First Customer Receipt Goes Viral, Bezos and Musk React

just now

Global Oil Prices Surge; Norway Reopens North Sea Fields

just now

Kwankwaso Meets NDC Chair to Resolve Kano Crisis

just now

BFREE Secures Growth Funding for Pan-African Credit Business

2m ago